Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Epigenetics-Bromodomain-GSK852
GSK852

Chemical Structure : GSK852

CAS No.: 2305842-30-0

GSK852 (GSK-852)

Catalog No.: PC-72183Not For Human Use, Lab Use Only.

GSK852 (GSK-852) is a highly potent, second bromodomain (BD2)-selective BET inhibitor with pIC50 7.9 (BRD4 BD2), 1260-fold selectivity over BRD4 BD1.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    GSK852 (GSK-852) is a highly potent, second bromodomain (BD2)-selective BET inhibitor with pIC50 7.9 (BRD4 BD2), 1260-fold selectivity over BRD4 BD1.
    GSK852 demonstrates highly soluble with good in vivo rat and dog pharmacokinetics.

    Physicochemical Properties

    M.Wt 406.482
    Formula C24H26N2O4
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    (3S)-N5-((1R,3R,5S)-3-hydroxybicyclo[3.1.0]hexan-6-yl)-N7,3-dimethyl-3-phenyl-2,3-dihydrobenzofuran-5,7-dicarboxamide

    References

    1. Simon C C Lucas, et al. J Med Chem. 2021 Aug 12;64(15):10711-10741.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: